tiprankstipranks
Trending News
More News >
Sumitomo Dainippon Pharma Co Ltd (JP:4506)
:4506
Japanese Market

Sumitomo Dainippon Pharma Co (4506) Income Statement

Compare
1 Followers

Sumitomo Dainippon Pharma Co Income Statement

Last quarter (Q4 2024), Sumitomo Dainippon Pharma Co's total revenue was ¥105.65B, an increase of 32.84% from the same quarter last year. In Q4, Sumitomo Dainippon Pharma Co's net income was ¥2.42B. See Sumitomo Dainippon Pharma Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 398.83B¥ 314.56B¥ 555.54B¥ 560.03B¥ 515.95B
Gross Profit
¥ 245.40B¥ 187.98B¥ 376.63B¥ 402.91B¥ 378.18B
Operating Expenses
¥ 230.47B¥ 542.17B¥ 331.74B¥ 342.67B¥ 306.95B
Depreciation and Amortization
¥ 25.56B¥ 37.77B¥ 41.26B¥ 38.35B¥ 22.67B
EBITDA
¥ 57.58B¥ -281.07B¥ -3.50B¥ 124.36B¥ 103.11B
Operating Income
¥ 14.93B¥ -354.19B¥ -76.98B¥ 60.23B¥ 71.22B
Other Income/Expenses
¥ 3.59B¥ 31.75B¥ 29.06B¥ 22.73B¥ 6.63B
Pretax Income
¥ 18.52B¥ -323.11B¥ -47.92B¥ 82.96B¥ 77.85B
Net Income
¥ 23.63B¥ -314.97B¥ -74.51B¥ 56.41B¥ 56.22B
Per Share Metrics
Basic EPS
¥ 59.49¥ -792.79¥ -187.55¥ 141.99¥ 141.50
Diluted EPS
¥ 59.49¥ -792.79¥ -187.55¥ 141.99¥ 141.50
Weighted Average Shares Outstanding
397.29M 397.29M 397.29M 397.29M 397.29M
Weighted Average Shares Outstanding (Diluted)
397.29M 397.29M 397.29M 397.29M 397.29M
Currency in JPY

Sumitomo Dainippon Pharma Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis